Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment

We investigate adaptive designs that can be used to take advantage of increases in efficiency from the use of the covariate-adjusted log-rank test in trials with time-to-event endpoints. These adaptive designs are intended to address a key practical challenge in taking advantage of efficiency gains from this test, which is that the actual efficiency gain attained in a trial may differ from estimates of the efficiency gain at the design stage. We evaluate information-based interim monitoring and blinded event target adjustment (BETA) as tools for improving efficiency, focusing on statistical and operational trade-offs between these approaches. We show using two different data-generating processes that regression coefficients used in the construction of the covariate-adjusted log-rank test may increase over time. As a result, variance reductions from adjustment with the covariate-adjusted log-rank test may also increase with additional follow-up in the trial. This means that BETA, which estimates variance reductions at an interim time-point in order to decide the timing of interim and final analyses, may not fully take advantage of the attainable efficiency gains with covariate adjustment. Simulations that incorporate repeated testing compare trial designs in terms of power, duration, and sample size reduction. While information-based monitoring enables faster analyses when covariates are highly prognostic, it may be operationally burdensome. BETA offers logistical simplicity but may not fully realize the potential efficiency gains from covariate adjustment. Reducing sample size with either adaptive design is potentially risky, as losses from a longer trial duration arising from over-optimistic estimates of efficiency gains at the design stage may be much greater than savings from a smaller trial.

Authors

Institutions

Publication Details

Journal
Statistics in Medicine
Published
2026-04-30
DOI
https://doi.org/10.1002/sim.70577
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment

Daniel Backenroth, Ting Ye
Statistics in Medicine
Statistical Methods in Clinical Trials
article

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment

Daniel Backenroth, Ting Ye
article en

Abstract

We investigate adaptive designs that can be used to take advantage of increases in efficiency from the use of the covariate-adjusted log-rank test in trials with time-to-event endpoints. These adaptive designs are intended to address a key practical challenge in taking advantage of efficiency gains from this test, which is that the actual efficiency gain attained in a trial may differ from estimates of the efficiency gain at the design stage. We evaluate information-based interim monitoring and blinded event target adjustment (BETA) as tools for improving efficiency, focusing on statistical and operational trade-offs between these approaches. We show using two different data-generating processes that regression coefficients used in the construction of the covariate-adjusted log-rank test may increase over time. As a result, variance reductions from adjustment with the covariate-adjusted log-rank test may also increase with additional follow-up in the trial. This means that BETA, which estimates variance reductions at an interim time-point in order to decide the timing of interim and final analyses, may not fully take advantage of the attainable efficiency gains with covariate adjustment. Simulations that incorporate repeated testing compare trial designs in terms of power, duration, and sample size reduction. While information-based monitoring enables faster analyses when covariates are highly prognostic, it may be operationally burdensome. BETA offers logistical simplicity but may not fully realize the potential efficiency gains from covariate adjustment. Reducing sample size with either adaptive design is potentially risky, as losses from a longer trial duration arising from over-optimistic estimates of efficiency gains at the design stage may be much greater than savings from a smaller trial.

Statistics in MedicineVol. 45(10-12)
Johnson & Johnson (United States) (US), University of Washington (US)
Openalex Percentile: Top 9%
Statistical Methods in Clinical Trials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment — Daniel Backenroth, Ting Ye · Statistics in Medicine (2026) | TGRS Research Map | TGRS